{
    "clinical_study": {
        "@rank": "45094", 
        "arm_group": {
            "arm_group_label": "High Risk Oncohematological Patients", 
            "description": "Detection Aspergillus PCR technique and Aspergillus AGA technique"
        }, 
        "brief_summary": {
            "textblock": "ADVANCE THERAPY ASPERGILLOSIS INVASIVE BY PCR DETECTION"
        }, 
        "brief_title": "Aspergillus PCR Early Detection in High Risk Oncohematological Patients", 
        "completion_date": {
            "#text": "December 2012", 
            "@type": "Anticipated"
        }, 
        "condition": "Infections", 
        "condition_browse": {
            "mesh_term": "Aspergillosis"
        }, 
        "detailed_description": {
            "textblock": "ADVANCE THERAPY ASPERGILLOSIS INVASIVE IN PATIENTS HIGH RISK ONCOHEMATOLOGICAL PCR USING FOR\n      EARLY DETECTION OF ASPERGILLUS"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Signature of informed consent to participate in the study.\n\n          -  Adult patients (> 18 years), diagnosed with acute myelogenous leukemia or\n             myelodysplastic syndrome with chemotherapy (CT) intensive, or admitted to undergo\n             allogeneic hematopoietic progenitor cells, or transplantation with graft versus host\n             disease.\n\n          -  The patient should be included in this protocol from the start of their chemotherapy\n             or conditioning therapy as reflected in another section.\n\n        Exclusion Criteria:\n\n          -  Employment of antifungal prophylaxis (30 days prior to inclusion) with triazole /\n             polyene with activity against Aspergillus (itraconazole, voriconazole, posaconazole,\n             amphotericin B inhalation).\n\n          -  Use of other systemic antifungal activity against Aspergillus (amphotericin,\n             terbinafine, flucytosine, echinocandins, etc.). Therefore it will Fluconazole\n             prophylaxis exclusively.\n\n          -  Background of IFI proven / probable prior\n\n          -  Probable IFI / tested at the time of inclusion in the study.\n\n          -  Exclusion will cause a lack of compliance with the inclusion criteria.\n\n          -  Patients who have a lack of follow biweekly with galactomannan or PCR. Have a\n             bacterial infection not properly treated and controlled before starting empirical\n             antifungal treatment (according to the definition given above). And finally they have\n             a neutropenia of short duration that it creates a significant risk of IFI. This\n             information will not be known logically to include the patient in the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Probability Sample", 
            "study_pop": {
                "textblock": "The study population will consist of hematological patients at high risk of invasive\n        fungal infection. Like: Leukemia acute mieloblasticas, myelodysplastic syndrome, patients\n        with intensive chemotherapy and allogeneic hematopoietic transplantation."
            }
        }, 
        "enrollment": {
            "#text": "225", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 30, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01742026", 
            "org_study_id": "GETH-PCRAGA"
        }, 
        "intervention": [
            {
                "arm_group_label": "High Risk Oncohematological Patients", 
                "description": "Aspergillus DNA PCR technique", 
                "intervention_name": "Aspergillus PCR technique", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "High Risk Oncohematological Patients", 
                "description": "Aspergillus AGA technique", 
                "intervention_name": "Aspergillus AGA technique", 
                "intervention_type": "Procedure"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": "High risk aspergillosis infection patients", 
        "lastchanged_date": "December 3, 2012", 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Badalona", 
                        "country": "Spain", 
                        "state": "Barcelona", 
                        "zip": "08916"
                    }, 
                    "name": "Hospital Germans Trias i Pujol"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "A Coru\u00f1a", 
                        "country": "Spain", 
                        "zip": "15006"
                    }, 
                    "name": "Complejo Hospitalario de A Coru\u00f1a"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08035"
                    }, 
                    "name": "Hospital Vall d\u00b4Hebron"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Barcelona", 
                        "country": "Spain", 
                        "zip": "08036"
                    }, 
                    "name": "Hospital Clinic de Barcelona"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Girona", 
                        "country": "Spain", 
                        "zip": "17007"
                    }, 
                    "name": "Hospital Josep Trueta"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28034"
                    }, 
                    "name": "Hospital Ramon y Cajal"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Madrid", 
                        "country": "Spain", 
                        "zip": "28040"
                    }, 
                    "name": "Hospital Clinico San Carlos"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Murcia", 
                        "country": "Spain", 
                        "zip": "30008"
                    }, 
                    "name": "Hospital morales Meseguer"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Oviedo", 
                        "country": "Spain", 
                        "zip": "33006"
                    }, 
                    "name": "Hospital Central de Asturias"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Salamanca", 
                        "country": "Spain", 
                        "zip": "37007"
                    }, 
                    "name": "Hospital Universitario de Salamanca"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sevilla", 
                        "country": "Spain", 
                        "zip": "41013"
                    }, 
                    "name": "Hospital Virgen del Rocio"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Valencia", 
                        "country": "Spain", 
                        "zip": "46010"
                    }, 
                    "name": "Hospital Clinico de Valencia"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Zaragoza", 
                        "country": "Spain", 
                        "zip": "50009"
                    }, 
                    "name": "Hospital Clinico Lozano Blesa"
                }
            }
        ], 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_groups": "1", 
        "official_title": "ADVANCE THERAPY ASPERGILLOSIS INVASIVE IN PATIENTS HIGH RISK ONCOHEMATOLOGICAL PCR USING FOR EARLY DETECTION OF ASPERGILLUS", 
        "overall_official": [
            {
                "affiliation": "Hospital Universitario de Salamanca", 
                "last_name": "Lourdes Vazquez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Vall d\u00b4Hebron", 
                "last_name": "Isabel Ruiz, Md", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Virgen del Rocio", 
                "last_name": "Rocio Parody, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Ramon y Cajal", 
                "last_name": "Javier Lopez, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Clinic de Barcelona", 
                "last_name": "Montserrat Rovira, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "HOSPITAL GERMANS TRIAS I PUJOL", 
                "last_name": "Montserrat Batlle, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Central de Asturias", 
                "last_name": "Carlos Vallejo, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital de A Coru\u00f1a", 
                "last_name": "Rosario Varela, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Morales Meseguer", 
                "last_name": "Inmaculada Heras, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Clinico San Carlos", 
                "last_name": "Joaquin Diaz, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Clinico de Valencia", 
                "last_name": "Carlos Solano, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Lozano Blesa", 
                "last_name": "Maria Teresa Olave, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "H. Josep Trueta", 
                "last_name": "David Gallardo, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": [
                "Spain: Spanish Agency of Medicines", 
                "Spain: Ethics Committee"
            ], 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_outcome": {
            "description": "To value the percentage of patients with likely/proven invasive fungal infection, diagnosed using only AGA tecnique or using AGA and PCR tecniques together.", 
            "measure": "Efficacy of PCR technique for detection of Aspergillus DNA versus the standard technique for the determination of galactomannan Antigen (AGA) in serum", 
            "safety_issue": "No", 
            "time_frame": "18-20 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01742026"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Grupo Espanol de trasplantes hematopoyeticos y terapia celular", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "December 2012"
    }
}